Personal genomic testing companies 23andMe (Mountain View, Calif.) and Navigenics (Redwood Shores, Calif.) have reportedly received licenses from the California Department of Public Health (CDPH) and are allowed to continue to do business in the state. Calls to the companies, as well as to the CDPH, were not returned by press time.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

September 2008 - Table of Contents

LIR September 2008 (full PDF issue)

Bad Debt, Weak Volumes Force Lower ’08 Guidance for LabCorp Despite Revenue Rise of 10%, Quest Up 12%

LabCorp Finalizes Stanford Outreach Acquisition for Rumored $30 Million

Legislative Update: New House Bill Seeks to Overhaul Lab Fee Schedule

ViraCor Labs Expecting 35% Rev Growth to $27 Million in 2009

Pod Lab UroPath Acquired by HealthTronics for $7.5 Million

EMRs Falling Short in the Lab as Push Continues for $100+ Billion Nationwide Network

Inside the Lab Industry: Bait and Switch an Issue as Lab Equipment Leasing Rates Climb

Navigenics, 23andMe Now Licensed to Test in California

Lab Stocks Showing Gains; Up 7% Over 5 Weeks, Up 4% for Year

Independent Labs Ineligible for CMS’s PQRI Program